Glutamate receptor δ2 serum antibodies in pediatric opsoclonus myoclonus ataxia syndrome.

MLA

Berridge, Georgina, et al. “Glutamate Receptor Δ2 Serum Antibodies in Pediatric Opsoclonus Myoclonus Ataxia Syndrome.” Neurology, vol. 91, no. 8, Aug. 2018, pp. e714–23. EBSCOhost, https://doi.org/10.1212/WNL.0000000000006035.

APA

Berridge, G., Menassa, D. A., Moloney, T., Waters, P. J., Welding, I., Thomsen, S., Zuberi, S., Fischer, R., Radu Aricescu, A., Pike, M., Dale, R. C., Kessler, B., Vincent, A., Ming Lim, Irani, S. R., Lang, B., Aricescu, A. R., & Lim, M. (2018). Glutamate receptor δ2 serum antibodies in pediatric opsoclonus myoclonus ataxia syndrome. Neurology, 91(8), e714–e723. https://doi.org/10.1212/WNL.0000000000006035

Chicago

Berridge, Georgina, David A. Menassa, Teresa Moloney, Patrick J. Waters, Imogen Welding, Selina Thomsen, Sameer Zuberi, et al. 2018. “Glutamate Receptor Δ2 Serum Antibodies in Pediatric Opsoclonus Myoclonus Ataxia Syndrome.” Neurology 91 (8): e714–23. doi:10.1212/WNL.0000000000006035.